Cargando…

Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag

JC virus, JCV, is a human neurotropic polyomavirus whose replication in glial cells causes the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML). In addition, JCV possesses oncogenic activity and expression of its transforming protein, large T-antigen (T-Ag), in several ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sariyer, Ilker Kudret, Merabova, Nana, Patel, Prem Kumer, Knezevic, Tijana, Rosati, Alessandra, Turco, Maria C., Khalili, Kamel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440322/ https://www.ncbi.nlm.nih.gov/pubmed/22984599 http://dx.doi.org/10.1371/journal.pone.0045000

Ejemplares similares

Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells
por: Sariyer, Ilker Kudret, et al.
Publicado: (2016)

Viral tumor antigen expression is no longer required in radiation-resistant subpopulation of JCV induced mouse medulloblastoma cells
por: Donadoni, Martina, et al.
Publicado: (2018)

Regulation of Human Neurotropic JC Virus Replication by Alternative Splicing Factor SF2/ASF in Glial Cells
por: Sariyer, Ilker Kudret, et al.
Publicado: (2011)

Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen
por: Gordon, Jennifer, et al.
Publicado: (2013)

JC Virus T-Antigen Regulates Glucose Metabolic Pathways in Brain Tumor Cells
por: Noch, Evan, et al.
Publicado: (2012)

HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity
por: Sami Saribas, A, et al.
Publicado: (2017)

Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
por: Schwab, Nicholas, et al.
Publicado: (2016)

BAG3: a new player in the heart failure paradigm
por: Knezevic, Tijana, et al.
Publicado: (2015)

SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells
por: Uleri, Elena, et al.
Publicado: (2013)

Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells
por: Craigie, Michael, et al.
Publicado: (2015)

Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway
por: Gain, Chandrima, et al.
Publicado: (2020)

Autophagy, EVs, and Infections: A Perfect Question for a Perfect Time
por: Pleet, Michelle L., et al.
Publicado: (2018)

JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
por: Diotti, Roberta Antonia, et al.
Publicado: (2013)

JCV seroconversion rate during the SARS COVID-19 pandemic
por: Vigiser, I., et al.
Publicado: (2022)

IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression
por: De-Simone, Francesca Isabella, et al.
Publicado: (2015)

BAG3 in the Heart
por: Turco, Maria Caterina
Publicado: (2023)

Alcohol exposure alters pre-mRNA splicing of antiapoptotic Mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons
por: Donadoni, Martina, et al.
Publicado: (2019)

Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation
por: Iannetta, Marco, et al.
Publicado: (2016)

No detection of EBV, BKV and JCV in breast cancer tissue samples in Iran
por: Dowran, Razieh, et al.
Publicado: (2019)

Anti-JCV antibody index does not change during ocrelizumab-treatment
por: Rempe, Torge, et al.
Publicado: (2020)

Oncoprotein ubiquitylation: Dimers, degrons, and degradation
por: Welcker, Markus, et al.
Publicado: (2014)

BAG3: a multifaceted protein that regulates major cell pathways
por: Rosati, A, et al.
Publicado: (2011)

Primary bilateral adrenal B-cell lymphoma associated with EBV and JCV infection
por: Barzon, Luisa, et al.
Publicado: (2009)

JC Virus Encephalopathy Is Associated with a Novel Agnoprotein-Deletion JCV Variant
por: Dang, Xin, et al.
Publicado: (2012)

Changes to anti-JCV antibody levels in a Swedish national MS cohort
por: Warnke, Clemens, et al.
Publicado: (2013)

Encephalitis with coinfection by Jamestown canyon virus (JCV) and varicella zoster virus (VZV)
por: VanderVeen, Nathan, et al.
Publicado: (2020)

Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation
por: Wu, Yuan-Hua, et al.
Publicado: (2018)

BAG3 regulates formation of the SNARE complex and insulin secretion
por: Iorio, V, et al.
Publicado: (2015)

Human JCV Infections as a Bio-Anthropological Marker of the Formation of Brazilian Amazonian Populations
por: Cayres-Vallinoto, Izaura M. V., et al.
Publicado: (2012)

Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy
por: Salmen, A., et al.
Publicado: (2016)

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients
por: Dwyer, Christopher M., et al.
Publicado: (2021)

BAG3 is required for IKKα nuclear translocation and emergence of castration resistant prostate cancer
por: Ammirante, M, et al.
Publicado: (2011)

Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy()
por: Ray, Dipankar, et al.
Publicado: (2015)

Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-Catenin in Colon Cancer
por: Ripple, Michael J., et al.
Publicado: (2014)

Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis
por: Hegen, Harald, et al.
Publicado: (2018)

The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway
por: Chen, Zhen-Hua, et al.
Publicado: (2017)

Toxicity in combined therapies for tumours treatments: a lesson from BAG3 in the TME?
por: Rosati, Alessandra, et al.
Publicado: (2023)

The anti-apoptotic BAG3 protein is involved in BRAF inhibitor resistance in melanoma cells
por: Guerriero, Luana, et al.
Publicado: (2017)

Targeting oncoproteins with a positive selection assay for protein degraders
por: Koduri, Vidyasagar, et al.
Publicado: (2021)

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
por: Kelm, Jeremy M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oskt2a4me9729gbv9mt25ae26m